Diverse Hematological Malignancies Including Hodgkin-like Lymphomas Develop in Chimeric MHC Class II Transgenic Mice

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Jan 5

PMID 20046882

Citations 5

Authors

Silke H Raffegerst

Gabriele Hoelzlwimmer

Sandra Kunder

Josef Mysliwietz

Leticia Quintanilla-Martinez

Dolores J Schendel

Affiliations

Soon will be listed here.

Abstract

A chimeric HLA-DR4-H2-E (DR4) homozygous transgenic mouse line spontaneously develops diverse hematological malignancies with high frequency (70%). The majority of malignancies were distributed equally between T and B cell neoplasms and included lymphoblastic T cell lymphoma (LTCL), lymphoblastic B cell lymphoma (LBCL), diffuse large B cell lymphoma (DLBCL), the histiocyte/T cell rich variant of DLBCL (DLBCL-HA/T cell rich DLBCL), splenic marginal zone lymphoma (SMZL), follicular B cell lymphoma (FBL) and plasmacytoma (PCT). Most of these neoplasms were highly similar to human diseases. Also, some non-lymphoid malignancies such as acute myeloid leukemia (AML) and histiocytic sarcoma were found. Interestingly, composite lymphomas, including Hodgkin-like lymphomas, were also detected that had CD30(+) Hodgkin/Reed-Sternberg (H/RS)-like cells, representing a tumor type not previously described in mice. Analysis of microdissected H/RS-like cells revealed their origin as germinal center B cells bearing somatic hypermutations and, in some instances, crippled mutations, as described for human Hodgkin lymphoma (HL). Transgene integration in an oncogene was excluded as an exclusive driving force of tumorigenesis and age-related lymphoma development suggests a multi-step process. Thus, this DR4 line is a useful model to investigate common molecular mechanisms that may contribute to important neoplastic diseases in man.

Citing Articles

Expression of A New Endogenous Retrovirus-Associated Transcript in Hodgkin Lymphoma Cells.

Schneider J, Volkmer I, Engel K, Emmer A, Staege M Int J Mol Sci. 2019; 20(21).

PMID: 31731509 PMC: 6862598. DOI: 10.3390/ijms20215320.

T Cell Receptor Profiling in Type 1 Diabetes.

Jacobsen L, Posgai A, Seay H, Haller M, Brusko T Curr Diab Rep. 2017; 17(11):118.

PMID: 29022222 PMC: 5636870. DOI: 10.1007/s11892-017-0946-4.

Prevention of Tumor Formation by Latent Gammaherpesvirus Infection.

Raffegerst S, Steer B, Hohloch M, Adler H PLoS One. 2015; 10(12):e0145678.

PMID: 26714031 PMC: 4699904. DOI: 10.1371/journal.pone.0145678.

Generation of human MHC (HLA-A11/DR1) transgenic mice for vaccine evaluation.

Zeng Y, Gao T, Zhao G, Jiang Y, Yang Y, Yu H Hum Vaccin Immunother. 2015; 12(3):829-36.

PMID: 26479036 PMC: 4964720. DOI: 10.1080/21645515.2015.1103405.

The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Luong K, Nguyn L Cancer Manag Res. 2013; 4:431-45.

PMID: 23293538 PMC: 3534394. DOI: 10.2147/CMAR.S39153.

References

Brauninger A, Hansmann M, Strickler J, Dummer R, Burg G, Rajewsky K . Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. N Engl J Med. 1999; 340(16):1239-47. DOI: 10.1056/NEJM199904223401604. View

Largaespada D . Genetic heterogeneity in acute myeloid leukemia: maximizing information flow from MuLV mutagenesis studies. Leukemia. 2000; 14(7):1174-84. DOI: 10.1038/sj.leu.2401852. View

Bellan C, Lazzi S, Zazzi M, Lalinga A, Palummo N, Galieni P . Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?. Diagn Mol Pathol. 2002; 11(1):2-8. DOI: 10.1097/00019606-200203000-00002. View

Henegariu O, Heerema N, Lowe Wright L, Ward D, Vance G . Improvements in cytogenetic slide preparation: controlled chromosome spreading, chemical aging and gradual denaturing. Cytometry. 2001; 43(2):101-9. View

Janz S . Myc translocations in B cell and plasma cell neoplasms. DNA Repair (Amst). 2006; 5(9-10):1213-24. DOI: 10.1016/j.dnarep.2006.05.017. View

Kapp U, Wolf J, Hummel M, Pawlita M, von Kalle C, DALLENBACH F . Hodgkin's lymphoma-derived tissue serially transplanted into severe combined immunodeficient mice. Blood. 1993; 82(4):1247-56. View

Padovan E, Giachino C, Cella M, Valitutti S, Acuto O, Lanzavecchia A . Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion. J Exp Med. 1995; 181(4):1587-91. PMC: 2191970. DOI: 10.1084/jem.181.4.1587. View

Lin Y, Nichols R, Letterio J, Aplan P . Notch1 mutations are important for leukemic transformation in murine models of precursor-T leukemia/lymphoma. Blood. 2005; 107(6):2540-3. PMC: 1414627. DOI: 10.1182/blood-2005-07-3013. View

Hoogervorst E, van Steeg H, de Vries A . Nucleotide excision repair- and p53-deficient mouse models in cancer research. Mutat Res. 2005; 574(1-2):3-21. DOI: 10.1016/j.mrfmmm.2005.01.018. View

10.

Sonderstrup G, Cope A, Patel S, Congia M, Hain N, Hall F . HLA class II transgenic mice: models of the human CD4+ T-cell immune response. Immunol Rev. 2000; 172:335-43. DOI: 10.1111/j.1600-065x.1999.tb01377.x. View

11.

Ward J . Lymphomas and leukemias in mice. Exp Toxicol Pathol. 2006; 57(5-6):377-81. DOI: 10.1016/j.etp.2006.01.007. View

12.

Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P . The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci U S A. 1993; 90(9):4319-23. PMC: 46498. DOI: 10.1073/pnas.90.9.4319. View

13.

Morse 3rd H, Anver M, Fredrickson T, Haines D, Harris A, Harris N . Bethesda proposals for classification of lymphoid neoplasms in mice. Blood. 2002; 100(1):246-58. DOI: 10.1182/blood.v100.1.246. View

14.

Kuppers R, KANZLER H, Hansmann M, Rajewsky K . Single cell analysis of Hodgkin/Reed-Sternberg cells. Ann Oncol. 1996; 7 Suppl 4:27-30. DOI: 10.1093/annonc/7.suppl_4.s27. View

15.

Eriksson B, JOHANSSON A, Roos G, Levan G, Holmberg D . Establishment and characterization of a mouse strain (TLL) that spontaneously develops T-cell lymphomas/leukemia. Exp Hematol. 1999; 27(4):682-8. DOI: 10.1016/s0301-472x(99)00003-x. View

16.

Deshpande A, Buske C . Lymphoid progenitors as candidate cancer stem cells in AML: new perspectives. Cell Cycle. 2007; 6(5):543-5. DOI: 10.4161/cc.6.5.3968. View

17.

Giudicelli V, Chaume D, Lefranc M . IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 2004; 32(Web Server issue):W435-40. PMC: 441550. DOI: 10.1093/nar/gkh412. View

18.

Simpson E, Chandler P, Sponaas A, Millrain M, Dyson P . T cells with dual antigen specificity in T cell receptor transgenic mice rejecting allografts. Eur J Immunol. 1995; 25(10):2813-7. DOI: 10.1002/eji.1830251015. View

19.

Lim M, Beaty M, Sorbara L, Cheng R, Pittaluga S, Raffeld M . T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells. Am J Surg Pathol. 2002; 26(11):1458-66. DOI: 10.1097/00000478-200211000-00008. View

20.

Kunder S, Calzada-Wack J, Holzlwimmer G, Muller J, Kloss C, Howat W . A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: analysis of mouse specific and human antibodies cross-reactive with murine tissue. Toxicol Pathol. 2007; 35(3):366-75. DOI: 10.1080/01926230701230296. View